2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features

被引：580

作者：

Beukelman, Timothy ^{[1
]}

Patkar, Nivedita M. ^{[1
]}

Saag, Kenneth G. ^{[1
]}

Tolleson-Rinehart, Sue ^{[2
]}

Cron, Randy Q. ^{[1
]}

DeWitt, Esi Morgan ^{[3
]}

Ilowite, Norman T. ^{[4
]}

Kimura, Yukiko ^{[5
]}

Laxer, Ronald M. ^{[6
,7
]}

Lovell, Daniel J. ^{[3
]}

Martini, Alberto ^{[8
,9
]}

Rabinovich, C. Egla ^{[10
]}

Ruperto, Nicolino ^{[8
,9
]}

机构：

[1] Univ Alabama Birmingham, Birmingham, AL 35233 USA

[2] Univ N Carolina, Chapel Hill, NC USA

[3] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA

[4] Childrens Hosp Montefiore, Bronx, NY USA

[5] Hackensack Univ, Med Ctr, Sanzari Childrens Hosp, Hackensack, NJ USA

[6] Univ Toronto, Toronto, ON, Canada

[7] Hosp Sick Children, Toronto, ON M5G 1X8, Canada

[8] Univ Genoa, Genoa, Italy

[9] IRCCS Ist G Gaslini, Genoa, Italy

[10] Duke Univ, Durham, NC USA

来源：

ARTHRITIS CARE & RESEARCH | 2011年 / 63卷 / 04期

基金：

美国医疗保健研究与质量局;

关键词：

ANTITUMOR NECROSIS FACTOR; INTRAARTICULAR TRIAMCINOLONE HEXACETONIDE; MODIFYING ANTIRHEUMATIC DRUGS; ALPHA MONOCLONAL-ANTIBODY; PLACEBO-CONTROLLED TRIAL; USSR DOUBLE-BLIND; TERM-FOLLOW-UP; CORTICOSTEROID INJECTION; PROGNOSTIC-FACTORS; EARLY PREDICTORS;

D O I：

10.1002/acr.20460

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient's individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed or endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice.

引用

页码：465 / 482

页数：18

共 118 条

[11] Breit W, 2000, J RHEUMATOL, V27, P2696
[12] PENICILLAMINE AND HYDROXYCHLOROQUINE IN THE TREATMENT OF SEVERE JUVENILE RHEUMATOID-ARTHRITIS - RESULTS OF THE USA USSR DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
BREWER, EJ
GIANNINI, EH
KUZMINA, N
ALEKSEEV, L
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (20) : 1269 - 1276
[13] BREWER EJ, 1982, J RHEUMATOL, V9, P123
[14] Low-dose methotrexate treatment for oligoarticular juvenile idiopathic arthritis nonresponsive to intra-articular corticosteroids
Brik, R
Gepstein, V
Berkovitz, D
[J]. CLINICAL RHEUMATOLOGY, 2005, 24 (06) : 612 - 614
[15] Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists
Carmona, L
Gómez-Reino, JJ
Rodríguez-Valverde, V
Montero, D
Pascual-Gómez, E
Mola, EM
Carreño, L
Figueroa, T
[J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (06): : 1766 - 1772
[16] *CENT ORTH BIOT, 2010, INFL PACK INS
[17] Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
Cohen, Stanley B.
Emery, Paul
Greenwald, Maria W.
Dougados, Maxime
Furie, Richard A.
Genovese, Mark C.
Keystone, Edward C.
Loveless, James E.
Burmester, Gerd-Ruediger
Cravets, Matthew W.
Hessey, Eva W.
Shaw, Timothy
Totoritis, Mark C.
[J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : 2793 - 2806
[18] Development and Validation of a Composite Disease Activity Score for Juvenile Idiopathic Arthritis
Consolaro, Alessandro
Ruperto, Nicolino
Bazso, Anna
Pistorio, Angela
Magni-Manzoni, Silvia
Filocamo, Giovanni
Malattia, Clara
Viola, Stefania
Martini, Alberto
Ravelli, Angelo
[J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (05): : 658 - 666
[19] EARLEY A, 1988, CLIN EXP RHEUMATOL, V6, P153
[20] Eberhard BA, 2004, J RHEUMATOL, V31, P2507

← 1 2 3 4 5 6 7 8 9 10 →